Our peak young man Yu Wang Yang
Release time:
2023-05-04
in Wang yang
age: 25 years old
post: group office
entry time: August 2019
"peak second generation"
first saw in Wang yang, in the summer of 2019, in Huang ping peak project construction headquarters. Just a few days after he went to work, he was thin, tall, white and clean, looking very quiet. In the project team at that time, his appearance was somewhat "against harmony"-the plateau had strong light, the construction site conditions were poor, and the others had been deeply exposed to several colors. Later, when the project was put into production, the "old-timers" often used him to "talk about things" when they joked: "I can get a tan when I am younger. Do you think it's hard for Huang Ping to live here?"
Because his mother was a peak employee, Yu Wangyang was influenced by "peak" since he was a child. When he was in primary school, he often went to the peak building after school, waiting for his mother to leave work while doing his homework. With this origin, it seems logical to become a peak person after graduating from university. However, although he studied information management, he was sent to Huang Ping, who was thousands of miles away from home. At that time, the project was still in the stage of civil engineering and equipment entering the factory. Yu Wang yang either received equipment and weighed it, or contacted and coordinated between the delivery driver and the construction unit. what he did was nothing to do with informatization. When there was not enough manpower for the equipment to enter the site, he went to the construction site to carry the machine without any evasions. Colleagues all said that this young man looked like he had never suffered, but he was never vague in his work, which was good.
With the advancement of equipment installation, Yu Wang Yang's professional knowledge gradually began to come in handy. He participated in the whole process of combing and optimizing the automatic control process of Huang Ping's peak production line and building the intelligent management framework. The application of textbook knowledge in practice also gave him a lot of new ideas about informatization, especially when he went to the China Cement Intelligence Summit Forum in the second half of 2020, and learned a lot of cutting-edge information, which made him deeply touched. After coming back, he wrote "My Opinion on the Trend of Peak Cement to" Intelligent Building ", and talked about his views on intelligent management in combination with the production situation of Peak in Huang Ping. This year, he was also named Huang Ping Jianfeng's innovation expert and shared his work experience at the commendation meeting.
2021 , Yu Wang yang was transferred back to the group headquarters. the plot when he first entered the company was repeated again, and he was sent to the internationalization project of the pharmaceutical company as soon as he reported for duty. Although cement and pharmaceutical industry are two completely different industries, with Huang Ping's practical experience, he quickly entered the role and did a lot of work in the application and optimization of the information management system of the new project. it has been unanimously recognized by leaders and colleagues.
2023 At the beginning of the New Year, Yu Wang Yang, who has been in the group office for three years, finally has his own desk in the department. However, in the past few months, he has often not been seen in the office, because he has to run at both ends to meet the certification of international projects. Not long ago, the company established the "Digital Intelligence Factory" Construction Promotion Committee, and Yu Wang Yang naturally became a member of the working group. The construction of "Digital Intelligence Factory" involves the headquarters and all subordinate enterprises, which is the focus of the company's current management improvement. In the next few days, he will still be busy. (Reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31